Proficio Capital Partners LLC Buys New Position in The Cooper Companies, Inc. (NASDAQ:COO)

Proficio Capital Partners LLC bought a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 94,504 shares of the medical device company's stock, valued at approximately $95,000.

Several other hedge funds and other institutional investors have also bought and sold shares of COO. Covestor Ltd lifted its holdings in Cooper Companies by 144.9% in the third quarter. Covestor Ltd now owns 338 shares of the medical device company's stock valued at $37,000 after buying an additional 200 shares during the period. Ashton Thomas Securities LLC acquired a new position in shares of Cooper Companies during the third quarter valued at about $25,000. GSA Capital Partners LLP raised its holdings in shares of Cooper Companies by 150.6% during the third quarter. GSA Capital Partners LLP now owns 6,993 shares of the medical device company's stock valued at $772,000 after purchasing an additional 4,202 shares during the period. Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Cooper Companies by 1.5% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 443,863 shares of the medical device company's stock valued at $48,976,000 after purchasing an additional 6,489 shares during the period. Finally, KBC Group NV raised its holdings in shares of Cooper Companies by 5.1% during the third quarter. KBC Group NV now owns 258,460 shares of the medical device company's stock valued at $28,519,000 after purchasing an additional 12,435 shares during the period. Institutional investors and hedge funds own 24.39% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Stifel Nicolaus dropped their price objective on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Friday, March 7th. JPMorgan Chase & Co. lowered their target price on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Friday, March 7th. Citigroup lowered their target price on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Finally, Wells Fargo & Company upped their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, December 6th. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $111.89.

Remove Ads

Cooper Companies Price Performance

NASDAQ COO traded up $3.49 on Friday, hitting $81.22. The stock had a trading volume of 2,436,699 shares, compared to its average volume of 1,255,216. The firm has a 50-day moving average of $91.20 and a 200-day moving average of $98.93. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The company has a market capitalization of $16.24 billion, a price-to-earnings ratio of 41.65, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 52-week low of $77.05 and a 52-week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. The firm had revenue of $964.70 million for the quarter, compared to analysts' expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Equities analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.